拓新药业(301089)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301089 拓新药业

已收盘 07-30 15:00:00

{"stockData":{"symbol":"301089","market":"SZ","secType":"STK","nameCN":"拓新药业","latestPrice":35.9,"timestamp":1753858980000,"preClose":36.36,"halted":0,"volume":10620003,"delay":0,"changeRate":-0.0127,"floatShares":90976299,"shares":127000000,"eps":-0.2017,"marketStatus":"已收盘","change":-0.46,"latestTime":"07-30 15:00:00","open":36.15,"high":37,"low":35.16,"amount":385000000,"amplitude":0.0506,"askPrice":35.91,"askSize":168,"bidPrice":35.9,"bidSize":617,"shortable":0,"etf":0,"ttmEps":-0.2017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":5,"adr":0,"adjPreClose":36.36,"symbolType":"stock","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":40,"lowLimit":32.72,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":126544500,"isCdr":false,"pbRate":2.97,"roa":"--","roe":"--","epsLYR":-0.16,"committee":0.474305,"marketValue":4543000000,"turnoverRate":0.1167,"status":1,"floatMarketCap":3266000000},"requestUrl":"/m/hq/s/301089","defaultTab":"news","newsList":[{"id":"2551149214","title":"拓新药业(301089.SZ)拟1000万元增资入股仅三生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2551149214","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551149214?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:24","pubTimestamp":1752657848,"startTime":"0","endTime":"0","summary":"智通财经APP讯，拓新药业 发布公告，公司将以自有资金1000万元对江苏仅三生物科技有限公司进行增资，其中22.3377万元计入注册资本，剩余部分计入资本公积。公司与仅三生物签署《关于江苏仅三生物科技有限公司之增资协议》，本次交易完成后，公司将直接持有仅三生物1.75%的股权。仅三生物凭借在菌株构建、发酵、提纯及工程化量产等全链条技术上的突破，成功实现了高纯度麦角硫因的制备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2549538049","title":"拓新药业：全资子公司胞磷胆碱原料药获得上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2549538049","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549538049?lang=zh_cn&edition=full","pubTime":"2025-07-07 17:55","pubTimestamp":1751882154,"startTime":"0","endTime":"0","summary":"金融界7月7日消息，近日，拓新药业全资子公司新乡制药股份有限公司胞磷胆碱原料药收到国家药监局签发的《化学原料药上市申请批准通知书》，并在药审中心官网公示。胞磷胆碱为临床常用神经保护剂等。此次获批标志该产品符合国家药品审评标准，完成 GMP 符合性检查后将具备国内生产销售资格，能拓宽公司产品线，增强竞争力，推动拓展国内原料药市场，但销售或受多种不确定因素影响。\n\n\r\n            责任编辑：钟离","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/07175551533207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2543677087","title":"拓新药业(301089.SZ)股东伊沃斯完成减持 合计减持2.47%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2543677087","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543677087?lang=zh_cn&edition=full","pubTime":"2025-06-16 20:55","pubTimestamp":1750078507,"startTime":"0","endTime":"0","summary":"智通财经APP讯，拓新药业(301089.SZ)公告，公司控股股东、实际控制人杨西宁之一致行动人新乡市伊沃斯商贸有限公司(简称“伊沃斯”)截至2025年6月13日通过集中竞价、大宗交易累计减持312.21万股，占公司总股本的2.47%，本次减持期间结束。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2541327098","title":"6月6日拓新药业现3笔折价19.45%的大宗交易 合计成交1589.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541327098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541327098?lang=zh_cn&edition=full","pubTime":"2025-06-06 17:08","pubTimestamp":1749200918,"startTime":"0","endTime":"0","summary":"证券之星消息，6月6日拓新药业发生大宗交易，交易数据如下：近三个月该股共发生13笔大宗交易，合计成交1.86万手，折价成交13笔。该股近期无解禁股上市。截至2025年6月6日收盘，拓新药业(301089)报收于32.39元，下跌0.67%，换手率7.73%，成交量7.03万手，成交额2.29亿元。该股近半年内有股东持股变动，合计净减持233.19万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600025834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301089"],"gpt_icon":0},{"id":"2540445727","title":"拓新药业6月3日现2笔大宗交易 总成交金额506.8万元 其中机构买入506.8万元 溢价率为-16.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540445727","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540445727?lang=zh_cn&edition=full","pubTime":"2025-06-03 17:00","pubTimestamp":1748941200,"startTime":"0","endTime":"0","summary":"　　6月3日，拓新药业收涨2.94%，收盘价为33.60元，发生2笔大宗交易，合计成交量18.1万股，成交金额506.8万元。　　第2笔成交价格为28.00元，成交10.80万股，成交金额302.40万元，溢价率为-16.67%，买方营业部为机构专用，卖方营业部为中国中金财富证券有限公司河南分公司。　　进一步统计，近3个月内该股累计发生10笔大宗交易，合计成交金额为3429.79万元。该股近5个交易日累计上涨2.00%，主力资金合计净流出3840.81万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-06-03/doc-ineyutxc1357001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2540745748","title":"拓新药业实控人方套现3326万元 2021上市中天国富保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2540745748","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540745748?lang=zh_cn&edition=full","pubTime":"2025-06-03 11:17","pubTimestamp":1748920620,"startTime":"0","endTime":"0","summary":"以拓新药业5月30日收盘价32.64元计算，伊沃斯本次减持套现约3326.34万元。拓新药业于2021年10月27日在深交所创业板上市，公开发行数量为3150万股，发行价格为19.11元/股，保荐机构、主承销商为中天国富证券有限公司，保荐代表人为常江、彭德强。拓新药业发行费用合计5869.09万元，其中保荐机构、主承销商中天国富证券有限公司获得保荐及承销费4504.65万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-06-03/doc-ineyuiii1513859.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-06-03/doc-ineyuiii1513859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2538542632","title":"5月28日拓新药业现1笔折价15.01%的大宗交易 合计成交203.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538542632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538542632?lang=zh_cn&edition=full","pubTime":"2025-05-28 17:13","pubTimestamp":1748423586,"startTime":"0","endTime":"0","summary":"证券之星消息，5月28日拓新药业发生大宗交易，交易数据如下：大宗交易成交价格27.12元，相对当日收盘价折价15.01%，成交7.5万股，成交金额203.4万元，买方营业部为机构专用，卖方营业部为中国中金财富证券有限公司河南分公司。近三个月该股共发生6笔大宗交易，合计成交8620.0手，折价成交6笔。截至2025年5月28日收盘，拓新药业报收于31.91元，下跌5.28%，换手率12.56%，成交量11.43万手，成交额3.72亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052800026498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301089"],"gpt_icon":0},{"id":"2538245951","title":"5月27日拓新药业现2笔折价16.89%的大宗交易 合计成交1041.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538245951","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538245951?lang=zh_cn&edition=full","pubTime":"2025-05-27 17:11","pubTimestamp":1748337067,"startTime":"0","endTime":"0","summary":"证券之星消息，5月27日拓新药业发生大宗交易，交易数据如下：近三个月该股共发生5笔大宗交易，合计成交7870.0手，折价成交5笔。该股近期无解禁股上市。截至2025年5月27日收盘，拓新药业(301089)报收于33.69元，上涨2.28%，换手率13.93%，成交量12.67万手，成交额4.2亿元。该股近半年内有股东持股变动，合计净减持131.28万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052700026025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301089"],"gpt_icon":0},{"id":"2538276147","title":"【医药股集体调整 海辰药业跌超10%】医药股早盘集体调整，海辰药业跌超10%，科源制药、河化股份、拓新药业、睿智医药、海南海药、多瑞医药、哈三联等多股跌超5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538276147","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538276147?lang=zh_cn&edition=full","pubTime":"2025-05-26 09:53","pubTimestamp":1748224431,"startTime":"0","endTime":"0","summary":"医药股早盘集体调整，海辰药业跌超10%，科源制药、河化股份、拓新药业、睿智医药、海南海药、多瑞医药、哈三联等多股跌超5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/26095350652027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002900","BK0146","159938","BK0010","BK0188","BK0060","BK0216","000953","300584","000566","301075","BK0239","09939","BK1574","BK0004","BK0077","301089","BK0070","BK1161","BK0066","BK1515","300149","301281","BK0071"],"gpt_icon":0},{"id":"2537150519","title":"每周股票复盘：拓新药业（301089）大宗交易折价20.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537150519","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537150519?lang=zh_cn&edition=full","pubTime":"2025-05-24 05:54","pubTimestamp":1748037255,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘，拓新药业报收于34.5元，较上周的37.78元下跌8.68%。本周，拓新药业5月20日盘中最高价报41.5元，股价触及近一年最高点。5月19日盘中最低价报33.77元。拓新药业当前最新总市值43.66亿元，在化学制药板块市值排名101/150，在两市A股市值排名3217/5148。本周关注点交易信息汇总: 5月20日拓新药业出现一笔折价20.01%的大宗交易，合计成交216.37万元交易信息汇总5月20日拓新药业出现一笔折价20.01%的大宗交易，合计成交金额为216.37万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400008568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2536269573","title":"遭股东减持，拓新药业大幅回撤，此前录得20CM两连板","url":"https://stock-news.laohu8.com/highlight/detail?id=2536269573","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536269573?lang=zh_cn&edition=full","pubTime":"2025-05-19 13:36","pubTimestamp":1747632984,"startTime":"0","endTime":"0","summary":"此前连续2日涨停的拓新药业(301089.SZ)盘中大幅回撤超10%，现报35.3元，总市值44.6亿元。消息上，拓新药业上周五晚间公告，公司控股股东、实际控制人杨西宁之一致行动人新乡市伊沃斯商贸有限公司于2025年3月14日至5月15日期间通过集中竞价、大宗交易累计减持131.28万股，占公司总股本的1.04%。值得一提的是，该股此前录得20CM两连板，并且股价刷新阶段新高。\n\n\r\n            责任编辑：栎树","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2025/05/cms_20250519133625014.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/05/cms_20250519133625014.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/05/19133650489962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2535685390","title":"5月16日拓新药业发布公告，股东减持131.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2535685390","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535685390?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:01","pubTimestamp":1747400469,"startTime":"0","endTime":"0","summary":"证券之星消息，5月16日拓新药业发布公告《拓新药业:关于公司控股股东、实际控制人之一致行动人减持公司股份触及1%整数倍的公告》，其股东新乡市伊沃斯商贸有限公司于2025年3月14日至2025年5月15日间合计减持131.28万股，占公司目前总股本的1.0374%，变动期间该股股价上涨9.99%，截止5月15日收盘报31.48元。股东增减持详情见下表：根据拓新药业2025年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600036475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301089"],"gpt_icon":0},{"id":"2535900603","title":"拓新药业实控人之一致行动人减持131万股，占总股本1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535900603","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535900603?lang=zh_cn&edition=full","pubTime":"2025-05-16 20:42","pubTimestamp":1747399320,"startTime":"0","endTime":"0","summary":"5月16日，拓新药业（301089）发布公告，控股股东、实际控制人之一致行动人新乡市伊沃斯商贸有限公司于2025年3月14日至2025年5月15日期间通过集中竞价和大宗交易累计减持131万股，占公司总股本的1.04%。2025年一季度，拓新药业实现收入9699万元，归母净利润-356万元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-05-16/doc-inewukkt8342560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2535392459","title":"20CM两连板拓新药业：控股股东伊沃斯商贸有限公司在异动期间减持0.44%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2535392459","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535392459?lang=zh_cn&edition=full","pubTime":"2025-05-16 20:31","pubTimestamp":1747398674,"startTime":"0","endTime":"0","summary":"拓新药业(301089.SZ)发布股票交易异常波动公告。经核实，公司前期披露的信息不存在需要更正、补充之处，未发现近期公共传媒报道了可能或者已经对本公司股票交易价格产生较大影响的未公开重大信息。公司控股股东、实际控制人之一致行动人新乡市伊沃斯商贸有限公司在股票异常波动期间减持股份，减持方式包括集中竞价和大宗交易，合计减持0.44%。除上述股东外，其他董事、监事及高级管理人员在公司股票交易异常波动期间不存在买卖公司股票的行为。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600035320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301089"],"gpt_icon":0},{"id":"2535392555","title":"【拓新药业：股东伊沃斯商贸有限公司减持0.23%公司股份】拓新药业公告，公司股票在2025年5月15日和16日连续两个交易日累计偏离45.65%，属于异常波动。经核查，公司前期披露的信息不存在需要更正或补充之处，近期未发现可能对公司股票交易价格产生较大影响的未公开重大信息。公司控股股东和实际控制人不存在应披露而未披露的重大事项。股东伊沃斯商贸有限公司在股票异常波动期间通过集中竞价和大宗交易方式减持股份，占总股本比例为0.23%。公司2024年净利润为-1988.49万元，较2023年下降108.18%；2025年第一季度净利润为-356.47万元，较去年同期下降272.34%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535392555","media":"金融界","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535392555?lang=zh_cn&edition=full","pubTime":"2025-05-16 20:16","pubTimestamp":1747397801,"startTime":"0","endTime":"0","summary":"拓新药业公告，公司股票在2025年5月15日和16日连续两个交易日累计偏离45.65%，属于异常波动。经核查，公司前期披露的信息不存在需要更正或补充之处，近期未发现可能对公司股票交易价格产生较大影响的未公开重大信息。公司控股股东和实际控制人不存在应披露而未披露的重大事项。股东伊沃斯商贸有限公司在股票异常波动期间通过集中竞价和大宗交易方式减持股份，占总股本比例为0.23%。公司2024年净利润为-1988.49万元，较2023年下降108.18%；2025年第一季度净利润为-356.47万元，较去年同期下降272.34%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16201650461797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301089"],"gpt_icon":0},{"id":"2535996053","title":"20CM两连板拓新药业：伊沃斯于2025年3月14日至5月15日累计减持131.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2535996053","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535996053?lang=zh_cn&edition=full","pubTime":"2025-05-16 19:39","pubTimestamp":1747395558,"startTime":"0","endTime":"0","summary":"拓新药业(301089.SZ)公告称，公司控股股东、实际控制人杨西宁之一致行动人伊沃斯于2025年3月14日至5月15日期间通过集中竞价、大宗交易累计减持131.28万股，占公司总股本的1.04%。本次权益变动后，杨西宁及其一致行动人伊沃斯合计持有公司股份占公司总股本的比例由29.84%减少至28.80%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600033001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301089"],"gpt_icon":0},{"id":"2535365981","title":"5月16日AI制药（医疗）概念上涨0.98%，板块个股拓新药业、阳光诺和涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2535365981","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535365981?lang=zh_cn&edition=full","pubTime":"2025-05-16 17:26","pubTimestamp":1747387611,"startTime":"0","endTime":"0","summary":"5月16日，截至收盘，AI制药（医疗）概念上涨0.98%，板块资金流出40986.28万。上涨个股家数23个，下跌个股家数12个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16172650450574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK1574","01477","BK0216","BK0239","688621","301089","159891"],"gpt_icon":0},{"id":"2535330011","title":"拓新药业20.01%涨停，总市值47.81亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535330011","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535330011?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:20","pubTimestamp":1747376401,"startTime":"0","endTime":"0","summary":"5月16日，拓新药业盘中20.01%涨停，截至14:20，报37.78元/股，成交8.65亿元，换手率27.9%，总市值47.81亿元。截至5月9日，拓新药业股东户数1.68万，人均流通股5414股。2025年1月-3月，拓新药业实现营业收入9699.47万元，同比减少10.46%；归属净利润-356.47万元，同比减少272.34%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16142050442022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301089","BK0239"],"gpt_icon":0},{"id":"2535929337","title":"化学制药板块异动拉升，拓新药业领涨12.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535929337","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535929337?lang=zh_cn&edition=full","pubTime":"2025-05-16 13:55","pubTimestamp":1747374925,"startTime":"0","endTime":"0","summary":"5月16日，化学制药板块盘中上涨1.56%，拓新药业领涨12.45%，哈三联涨超10%，新华制药、亨迪药业涨超9%，森萱医药涨超7%。板块实时资金流向显示，今日超大单净流入4.11亿元，今日小单净流出2.24亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16135550441350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","01477","301089","BK1191","BK0239"],"gpt_icon":0},{"id":"2535902893","title":"5月15日拓新药业（301089）涨停分析：合成生物概念、原料药板块驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2535902893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535902893?lang=zh_cn&edition=full","pubTime":"2025-05-15 15:32","pubTimestamp":1747294338,"startTime":"0","endTime":"0","summary":"证券之星消息，拓新药业5月15日涨停收盘，收盘价31.48元。今日拓新药业涨停的可能因素有：首先，合成生物概念板块近期表现活跃，同板块的川宁生物、金达威等个股涨幅显著，形成板块联动效应；其次，公司作为原料药及核苷(酸)类医药中间体领域的核心企业，其产品线覆盖化学合成与生物发酵技术，与合成生物技术存在产业协同，市场对其在生物医药创新领域的研发潜力保持关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051500018425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301089","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753870205162,"stockEarnings":[{"period":"1week","weight":0.0518},{"period":"1month","weight":0.1569},{"period":"3month","weight":0.4538},{"period":"6month","weight":0.3598},{"period":"1year","weight":0.2052},{"period":"ytd","weight":0.2898}],"compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0542},{"period":"3month","weight":0.1008},{"period":"6month","weight":0.1105},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.077}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"拓新药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20864人(较上一季度增加24.18%)","perCapita":"4360股","listingDate":"2021-10-27","address":"河南省新乡市红旗区高新区科隆大道515号","registeredCapital":"12654万元","survey":"　　拓新药业集团股份有限公司是集化学合成、生物发酵核苷（酸）类原料药及医药中间体的研发、生产及销售为一体的高新技术企业。主要产品有嘧啶系列、嘌呤系列、核苷酸系列、核苷系列等多个系列核苷（酸）类产品，包括胞磷胆碱钠、利巴韦林、肌苷、阿昔洛韦、胞嘧啶、5-氟胞嘧啶、胞苷等原料药及医药中间体，主要涵盖抗病毒、抗肿瘤和神经系统用药领域。公司始终将“研发创新”作为核心战略，高度重视产品研发投入和研发能力的提高，已建立了“河南省博士后研发基地”、“国家博士后科研工作站”，并荣获“国家高技术产业示范工程”、“河南省高新技术特色产业基地首批骨干企业”、“河南省企业技术中心”、“河南省核苷工程技术研究中心”等多项荣誉称号。此外，还获得了河南省科学技术进步一等奖、国家科学技术进步二等奖等重大科技奖项，并有多项产品入选“国家重点新产品”、“国家火炬计划项目”。","listedPrice":19.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"拓新药业(301089)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供拓新药业(301089)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"拓新药业,301089,拓新药业股票,拓新药业股票老虎,拓新药业股票老虎国际,拓新药业行情,拓新药业股票行情,拓新药业股价,拓新药业股市,拓新药业股票价格,拓新药业股票交易,拓新药业股票购买,拓新药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"拓新药业(301089)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供拓新药业(301089)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}